Literature DB >> 23714810

Medical decision-making among adolescents with neonatal brachial plexus palsy and their families: a qualitative study.

Lee Squitieri1, Bradley P Larson, Kate W-C Chang, Lynda J-S Yang, Kevin C Chung.   

Abstract

BACKGROUND: Elective surgical management of neonatal brachial plexus palsy is complex, variable, and often individualized. Little is known about the medical decision-making process among adolescents with neonatal brachial plexus palsy and their families when faced with making complex treatment decisions. The experiences of these patients and their parents were analyzed to identify key factors in the decision-making process.
METHODS: Eighteen adolescents with residual neonatal brachial plexus palsy deficits between 10 and 17 years and their parents were included. Qualitative research design was used involving separate, 1-hour, in person, semistructured interviews, which were audio recorded and transcribed. Grounded theory was applied by two members of the research team to identify recurrent themes and create a codebook that was applied to the data.
RESULTS: Medical decision-making among adolescents with neonatal brachial plexus palsy and their families is multifaceted and individualized, composed of both patient- and system-dependent factors. Four codes were identified: (1) knowledge acquisition, (2) multidisciplinary care, (3) adolescent autonomy, and (4) patient expectations and treatment desires. Overall, parental decision-making was heavily influenced by system-dependent factors, whereas adolescents largely based their decisions on individual treatment desires to improve function and/or aesthetics.
CONCLUSIONS: There are many areas for improving the delivery of information and health care organization among adolescents with neonatal brachial plexus palsy and their families. The authors recommend the development of educational interdisciplinary programs and decision aids containing evidence-based management guidelines targeted toward primary care providers and patients. The authors believe that a computer-based learning module may provide the best avenue to achieve maximum penetrance and convenience of information sharing. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, IV.

Entities:  

Mesh:

Year:  2013        PMID: 23714810      PMCID: PMC4784245          DOI: 10.1097/PRS.0b013e31828bd52b

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  6 in total

1.  Understanding quality of life and patient expectations among adolescents with neonatal brachial plexus palsy: a qualitative and quantitative pilot study.

Authors:  Lee Squitieri; Bradley P Larson; Kate W C Chang; Lynda J S Yang; Kevin C Chung
Journal:  J Hand Surg Am       Date:  2013-12       Impact factor: 2.230

2.  Coping with congenital hand differences.

Authors:  Lauren E Franzblau; Kevin C Chung; Noelle Carlozzi; Autumn Y T Chin; Kate W Nellans; Jennifer F Waljee
Journal:  Plast Reconstr Surg       Date:  2015-04       Impact factor: 4.730

Review 3.  The evaluation and management of neonatal brachial plexus palsy.

Authors:  Vibhuti Shah; Christopher J Coroneos; Eugene Ng
Journal:  Paediatr Child Health       Date:  2021-12-27       Impact factor: 2.253

4.  L'évaluation et la prise en charge de la paralysie néonatale du plexus brachial.

Authors:  Vibhuti Shah; Christopher J Coroneos; Eugene Ng
Journal:  Paediatr Child Health       Date:  2021-12-27       Impact factor: 2.253

5.  Obstetrical brachial plexus injury (OBPI): Canada's national clinical practice guideline.

Authors:  Christopher J Coroneos; Sophocles H Voineskos; Marie K Christakis; Achilleas Thoma; James R Bain; Melissa C Brouwers
Journal:  BMJ Open       Date:  2017-01-27       Impact factor: 2.692

Review 6.  Hand Function and Appearance following Reconstruction for Congenital Hand Differences: A Qualitative Analysis of Children and Parents.

Authors:  Brian P Kelley; Lauren E Franzblau; Kevin C Chung; Noelle Carlozzi; Jennifer F Waljee
Journal:  Plast Reconstr Surg       Date:  2016-07       Impact factor: 5.169

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.